Indo-MIM Cuts IPO Target Amid India's Sluggish Market

IPO
Whalesbook Logo
AuthorIshaan Verma|Published at:
Indo-MIM Cuts IPO Target Amid India's Sluggish Market
Overview

Precision components manufacturer Indo-MIM Ltd. is recalibrating its initial public offering in India, now targeting $2.5 billion in valuation, down from $3.2 billion. The company aims to raise up to $700 million through a public issue comprising a fresh equity sale and an offer for sale by existing investors. This move occurs against a backdrop of a subdued Indian IPO market in early 2026, with companies delaying listings due to secondary market downturns. Indo-MIM has received SEBI approval for its offering.

### IPO Valuation Adjustment Amid Market Headwinds

Precision components maker Indo-MIM Ltd. is moving forward with its India IPO plans, seeking to raise as much as $700 million. The company has revised its valuation target downwards to approximately $2.5 billion from an earlier projection of $3.2 billion. This adjustment reflects a cautious sentiment within the Indian capital markets at the start of 2026. The offering, which has received approval from the Securities and Exchange Board of India (SEBI) on December 29, 2025, is expected to include both the sale of new shares and a secondary offering by existing shareholders. Discussions regarding the final valuation and precise timing are ongoing.

### Indian IPO Market Faces Slowdown

Indo-MIM's proposed listing emerges at a time when India's primary market has experienced a weak start to 2026, a contrast to the record fundraising seen in the preceding year. Persistent volatility in the secondary market is prompting many companies to postpone their public offerings, awaiting more favorable valuation conditions. January 2026 saw only three IPOs launch, collectively raising approximately $518 million. Despite this, over 110 companies have secured regulatory approvals, signaling a substantial pipeline of potential listings.

### Deal Structure and Company Profile

The proposed offering is set to include new shares valued at approximately INR 1,000 crore, alongside a secondary sale of roughly 129.67 million shares. This secondary portion, representing 26% of the total equity capital, will be offloaded by existing investors, notably including the Indian Institute of Technology Madras. Net proceeds from the IPO are designated for repaying outstanding borrowings, with Rs 720 crore earmarked for debt repayment, and for general corporate purposes.

Indo-MIM specializes in manufacturing precision engineering components using metal injection molding (MIM) technology. It operates an extensive network of 15 manufacturing facilities, comprising six in India, six in the United States, two in the United Kingdom, and one in Mexico. As of fiscal year 2025, the company held an estimated 7% global market share in the MIM sector and is recognized as one of the world's largest producers by installed capacity. The company serves critical sectors including automotive, defense, medical, consumer goods, and aerospace.

### Financial Performance and Sector Outlook

For the fiscal year ended March 2025, Indo-MIM reported revenue from operations of INR 3,330 crore and a net income of INR 428 crore. The company has consistently invested in diverse manufacturing capabilities beyond MIM, such as investment casting, ceramic injection molding, precision machining, and metal 3D printing. The global MIM market is projected to grow from $3.7 billion in 2024 to $5.6 billion by 2029. Similarly, India's precision engineering market is expected to expand significantly, with projections indicating a valuation of $930 million by 2033 from $500 million in 2024, driven by sectors like automotive and aerospace.

### Recent Challenges and Advisors

Despite strong sector growth prospects, Indo-MIM faces potential headwinds. The US imposed significant tariffs on select Indian imports starting August 2025, creating material exposure for Indo-MIM, which derives 85-90% of its revenue from exports, with the US contributing 50-60% of its top-line. However, the company has demonstrated resilience, with Q1 FY2026 revenues growing over 43% year-on-year to INR 972.1 crore, suggesting that its specialized products may mitigate immediate pricing pressures.

A consortium of leading financial institutions, including Axis Bank Ltd., Kotak Mahindra Capital Co., SBI Capital Markets Ltd., ICICI Securities Ltd., and HDFC Bank Ltd., are advising on the share sale.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.